ACVRL1
ACVRL1 (activin A receptor like type 1, also known as ALK1, HHT2, ACVRLK1 and ORW2) is a type I cell-surface serine/threonine kinase receptor for TGF-beta family ligands. It is an important regulator of normal blood vessel development. Browse Assay Genie's current range of ACVRL1 research reagents below, or read on for the biology behind the target.
ACVRL1 is a type I receptor for the TGF-beta family ligands BMP9 (GDF2) and BMP10, and it plays an important part in normal blood vessel development. On ligand binding, it forms a receptor complex made up of two type II and two type I transmembrane serine/threonine kinases. Type II receptors phosphorylate and activate the type I receptors, which then autophosphorylate. The activated type I receptors bind and activate SMAD transcriptional regulators, which carries the signal to the nucleus. The protein may also bind activin.
The ACVRL1 gene encodes a cell-surface protein that belongs to the protein kinase superfamily, the TKL Ser/Thr protein kinase family and the TGFB receptor subfamily. HGNC places it among the type 1 receptor serine/threonine kinases and the BMP receptors. Like other type I receptors, it has highly similar serine-threonine kinase subdomains, a glycine- and serine-rich region called the GS domain that precedes the kinase domain, and a short C-terminal tail. It shares this domain structure with closely related ALK (activin receptor-like kinase) proteins, which form a subfamily of receptor serine/threonine kinases. Mouse and rat both have an ortholog named Acvrl1.
The protein is often called ALK1, and earlier names for the gene include activin A receptor type II-like 1 and activin A receptor type IL. Mutations in the ACVRL1 gene are associated with hereditary haemorrhagic telangiectasia type 2, also known as Rendu-Osler-Weber syndrome 2. This link makes the receptor a frequent subject in vascular biology and BMP signalling research, including work that uses an ACVRL1 antibody, an ACVRL1 ELISA kit or recombinant ACVRL1 protein.
ACVRL1 is an important regulator of normal blood vessel development, so it is a key target for studying how vessels form.
ACVRL1 is a type I receptor for BMP9/GDF2 and BMP10, which makes it central to work on these ligands.
Activated type I receptors bind and activate SMAD transcriptional regulators, so ACVRL1 is used to examine receptor complex assembly and downstream signalling.
Mutations in ACVRL1 are associated with hemorrhagic telangiectasia type 2 (Rendu-Osler-Weber syndrome 2), a focus of disease-oriented studies.
ACVRL1 is a type I receptor for BMP9/GDF2 and BMP10. After ligand binding it joins a complex of two type II and two type I serine/threonine kinases. Type II receptors activate it, and it then activates SMAD transcriptional regulators. It is important for normal blood vessel development.
ACVRL1 is also called ALK1, HHT2, HHT, ACVRLK1 and ORW2. Earlier names include activin A receptor type II-like 1 and activin A receptor type IL. UniProt lists the protein as activin receptor type-1-like, and the gene belongs to the BMP receptor group.
Mutations in ACVRL1 are associated with hemorrhagic telangiectasia type 2, also called Rendu-Osler-Weber syndrome 2. Mouse and rat each have an ortholog named Acvrl1. Check the datasheet of any product for its validated reactivity.
Other BMP and activin receptors, their ligands and SMAD pathway components that are relevant to ACVRL1 signalling.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P37023; product specifications from Assay Genie datasheets.